1Kadin ME.Anaplastic large cell lymphoma and its morphological variants.Cancer Surv,1997,30:77-86.
2Kinney MC,Collins RD,Greer JP,et al.Small cell predominant variant of primary Ki-1(CD30)+ T cell lymphoma.Am J Surg Pathol,1993,17:859-868.
3Pileri S,Falini B,Delsol G,et al.Lymphohistiocytic T cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes).Histopathology,1990,16:383-391.
4ten Berge RL,Oudejans JJ,Ossenkoppele GJ,et al.ALK-negative systemic anaplastic large cell lymphoma:differential diagnostic and prognostic aspects-a review.J Pathol,2003,200:4-15.
5Foss HD,Anagnostopoulos I,Araujo I,et al.Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.Blood,1996,88:4005-4011.
6Morris SW,Kirstein MN,Valentine MB,et al.Fusion of a kinase gene,ALK,to a nucleolar protein gene,NPM,in non-Hodgkin's lymphoma.Science,1994,263:1281-1284.
7Shiota M,Nakamura S,Ichinoshama R,et al.Anaplastic large cell lymphomas expressing the novel chimeric protein p80 NPM/ALK:a distinct clinicopathologic entity.Blood,1995,86:1954-1960.
8ten Berge RL,Dukers DF,Oudejans JJ,et al.Adverse effects of activated cytotoxic T-lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma.Blood,1999,93:2688-2696.
9Falini B,Pileri S,Zinzani PL,et al.ALK-positive lymphoma:clinicopathological findings and outcome.Blood,1999,93:2697-2706.
10Gascoyne RD,Aoun P,Wu D,et al.Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.Blood,1999,93:3913-3921.
4Benharroch D, Meguerian-Bedoyn Z, Lamant L, et al. ALK-positive lymphoma: A single disease with a broad spectrum of morphology [J]. Blood, 1998, 91 (16):2076.
5Kinney MC, Collins RD, Greet PJ, et al. A smallcell predominant variant of primary Ki-1 (CD30) + T-cell lym phoma [J]. Am J SurgPathol, 1993, 17 (9):859.
6Bayle C, Charpentier A, Duchayne E, et al. Leukaemic presentation of small cell variant anaplastic large cell lymphoma: Report of four cases [J]. Br J Haematol, 1999, 104 (4):680.
7Hodges KB, Collins RD, Greer JP, et al. Transformation of the small cell variant Ki-1 + lymphoma to anaplastic large cell lymphoma: Pathologic and clinical features [ J]. Am J SurgPathol, 1999, 23 (1):49.
8Woessmann W. Allogeneic haematopoietic stem cell tranplantation in relapsed or refractory anaplastic cell lymphomaof children and adolescents-a Berlin- Frankfuet-Munst, group report [J]. Br J Haematol, 2006, 133 : 176.
9Zinzani PL, Magagnoli M, Bendandi M, et al. Therel: with gemcitabine in Pretreated peripheral T-cell lymphotr patients [J]. AnnOncol, 1998, 9 (12): 1351.
10Forero A, Bemsein S, Gopal A, et al. Initial phaseⅡ results of SGN-30 (anti-CD-30 monoclonal antibody) in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL) [ J]. J Clin Oncol, 2005, 23: 58SS.
